232 related articles for article (PubMed ID: 29235098)
1. Hepcidin and DNA promoter methylation in hepatocellular carcinoma.
Udali S; Castagna A; Corbella M; Ruzzenente A; Moruzzi S; Mazzi F; Campagnaro T; De Santis D; Franceschi A; Pattini P; Gottardo R; Olivieri O; Perbellini L; Guglielmi A; Choi SW; Girelli D; Friso S
Eur J Clin Invest; 2018 Feb; 48(2):e12870. PubMed ID: 29235098
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
Li Z; Zhang H; Yang J; Hao T; Li S
Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of hepatic iron sensing genes and the regulation of hepcidin expression.
Sharp PA; Clarkson R; Hussain A; Weeks RJ; Morison IM
PLoS One; 2018; 13(5):e0197863. PubMed ID: 29771984
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin in hepatocellular carcinoma.
Joachim JH; Mehta KJ
Br J Cancer; 2022 Jul; 127(2):185-192. PubMed ID: 35264787
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
[TBL] [Abstract][Full Text] [Related]
6. Friend of GATA and GATA-6 modulate the transcriptional up-regulation of hepcidin in hepatocytes during inflammation.
Bagu ET; Layoun A; Calvé A; Santos MM
Biometals; 2013 Dec; 26(6):1051-65. PubMed ID: 24179092
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation suppresses liver Hamp expression in response to iron deficiency after bariatric surgery.
Huang Y; Zhang H; Wang C; Zhou J; Li Y; Hu C
Surg Obes Relat Dis; 2020 Jan; 16(1):109-118. PubMed ID: 31839527
[TBL] [Abstract][Full Text] [Related]
8. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.
Acun T; Oztas E; Yagci T; Yakicier MC
BMC Cancer; 2011 Jun; 11():223. PubMed ID: 21645397
[TBL] [Abstract][Full Text] [Related]
9. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
10. Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes.
Ouni M; Eichelmann F; Jähnert M; Krause C; Saussenthaler S; Ott C; Gottmann P; Speckmann T; Huypens P; Wolter S; Mann O; De Angelis MH; Beckers J; Kirchner H; Schulze MB; Schürmann A
Mol Metab; 2023 Sep; 75():101774. PubMed ID: 37429525
[TBL] [Abstract][Full Text] [Related]
11. Splicing variant of hepcidin mRNA.
Sasaki K; Kohgo Y; Ohtake T
Vitam Horm; 2019; 110():131-141. PubMed ID: 30798808
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inhibition of nuclear receptor small heterodimer partner is associated with and regulates hepatocellular carcinoma growth.
He N; Park K; Zhang Y; Huang J; Lu S; Wang L
Gastroenterology; 2008 Mar; 134(3):793-802. PubMed ID: 18325392
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of hDAB2IPA and hDAB2IPB in normal tissues and promoter methylation of hDAB2IPA in hepatocellular carcinoma.
Qiu GH; Xie H; Wheelhouse N; Harrison D; Chen GG; Salto-Tellez M; Lai P; Ross JA; Hooi SC
J Hepatol; 2007 Apr; 46(4):655-63. PubMed ID: 17258345
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of NF-κB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
Ng PKS; Lau CPY; Lam EKY; Li SSK; Lui VWY; Yeo W; Ng YK; Lai PBS; Tsui SKW
Dig Dis Sci; 2018 Mar; 63(3):676-686. PubMed ID: 29353445
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications.
Xu B; Di J; Wang Z; Han X; Li Z; Luo X; Zheng Q
Biochem Biophys Res Commun; 2013 Aug; 438(2):324-8. PubMed ID: 23891693
[TBL] [Abstract][Full Text] [Related]
19. A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.
Fujiwara T; Ikeda T; Nagasaka Y; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Ichinohasama R; Tomosugi N; Harigae H
PLoS One; 2013; 8(9):e75568. PubMed ID: 24086573
[TBL] [Abstract][Full Text] [Related]
20. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
